Unable to attend this year’s

ECCO Congress 2016?

View the full-length webcasts of 2 Takeda-sponsored symposia

of Ulcerative

Putting Patients
at the Center

Friday, 18 March 2016
18:05 - 19:05

Plenary Hall
RAI Amsterdam
The Netherlands

Speaker Biographies

Iris Dotan, MD

Head, Inflammatory Bowel Disease Center
Dept of Gastroenterology and Liver Diseases
Tel Aviv Sourasky Medical Center
Sackler Faculty of Medicine, Tel Aviv University
Tel Aviv, Israel

Iris Dotan, MD, is Head of the Inflammatory Bowel Disease (IBD) Center at Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, a tertiary referral center for patients with IBD. Prof Dotan received her MD from the Sackler Faculty of Medicine at Tel Aviv University, Tel Aviv. Her postdoctoral fellowship was completed at the Immunobiology Center at Mount Sinai Hospital in New York, New York, USA, and focused on intestinal epithelial cell biology. She is a specialist in internal medicine, gastroenterology, and liver diseases.

The overarching theme at the IBD Center is to provide cutting-edge care for patients and families. Prof Dotan's clinical and research interests focus on patient stratification as a basis for improved patient care, prevention of complications, and future cure of IBD. She has expertise in the use of biologics and novel therapies for IBD, and the follow-up of patients with UC before and after restorative proctocolectomy in a comprehensive, multidisciplinary pouch clinic. In addition, Prof Dotan conducts translational research in mucosal immunology focusing on the interactions of mucosal lymphocytes with their environment, specifically epithelial cell–derived mediators. She first described the new antiglycan antibodies and their relevance to Crohn's disease a decade ago, and is investigating the role of glycans in intestinal immune responses.

Peter Irving, MD

Consultant, Gastroenterology and General Internal Medicine
Guy's and St Thomas' NHS Foundation Trust
London, UK

Peter Irving, MD, is Lead for IBD at Guy's and St Thomas' Hospitals, and Honorary Senior Lecturer at King's College London, UK. Dr Irving studied medicine at the University of Cambridge, UK, and the Royal London Hospital, London, before training in gastroenterology in and around London. He undertook research in London and Australia before returning to the UK to take up a consultant post.

Dr Irving has published over 80 articles and book chapters, as well as 3 books on IBD, and is on the editorial boards of Inflammatory Bowel Diseases, Journal of Crohn's and Colitis, and Crohn's and Colitis UK. He is the UK national representative to ECCO and sits on that organization's Education Committee, as well as on the IBD Section of the British Society of Gastroenterology. Dr Irving has a variety of active research interests, both clinical and basic science, and is a member of the BRIDGe group, an international research collaborative of IBD investigators.

David Rubin, MD

Joseph B. Kirsner Professor of Medicine
Chief, Section of Gastroenterology, Hepatology and Nutrition
Co-Director, Digestive Diseases Center
The University of Chicago Medicine
Illinois, USA

David Rubin, MD, is the Joseph B. Kirsner Professor of Medicine, Chief of the Section of Gastroenterology, Hepatology and Nutrition, and Co-Director of the Digestive Diseases Center at The University of Chicago Medicine, Illinois, USA. Dr Rubin earned his MD with honors at The University of Chicago Pritzker School of Medicine. He completed his residency in internal medicine, and fellowships in gastroenterology and clinical medical ethics at The University of Chicago, where he was Chief Resident and Chief Fellow. Prior to his current appointments, Dr Rubin served for 11 years as Director of the Gastroenterology, Hepatology and Nutrition Fellowship Program. He also currently serves as Associate Faculty Member at The MacLean Center for Clinical Medical Ethics and Associate Investigator at The University of Chicago Comprehensive Cancer Center.

Dr Rubin is a Fellow of the American Gastroenterological Association, American College of Gastroenterology (ACG), American Society for Gastrointestinal Endoscopy, and American College of Physicians, and an active national member of the Crohn's & Colitis Foundation of America (CCFA), and serves on the ACG Board of Trustees. Among numerous awards and honors, he was selected by his peers as a member of Best Doctors (recognized for superior clinical ability) and America's Top Physicians (gastroenterology). In addition, Dr Rubin has received the ACG Governor's Award of Excellence in Clinical Research (in both 2003 and 2013), the Cancer Research Foundation Young Investigator's Award (2004), and The University of Chicago Postgraduate Teaching Award in recognition of significant contributions to fellowship education (2006). In 2012, he received the CCFA Rosenthal Award, a national leadership award bestowed on a volunteer who has contributed in an indisputable way to the quality of life of patients and their families.

Dr Rubin is Editor of a best-selling book on IBD, now in its 2nd edition, and an author or coauthor of many peer-reviewed articles on IBD. He is also a featured media contact for issues related to IBD, appearing on satellite radio and television, and in print media. His principal research interests include novel IBD therapies and outcomes, colon cancer prevention, and clinical medical ethics.